These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22522560)

  • 1. Serial optical coherence tomography imaging of the "black-hole" phenomenon by intravascular ultrasound following sirolimus-eluting stent implantation.
    Kurita T; Terashima M; Suzuki T
    EuroIntervention; 2012 Apr; 7(12):1480-1. PubMed ID: 22522560
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical "black hole" phenomenon after treatment of sirolimus stent restenosis with a paclitaxel-coated balloon.
    Linares Vicente JA; Lukic A; Gonzalo López N; Ruiz Arroyo JR
    EuroIntervention; 2012 Apr; 7(12):1479. PubMed ID: 22522559
    [No Abstract]   [Full Text] [Related]  

  • 3. Incomplete arterial healing 8 years after the implantation of sirolimus-eluting stent. In vivo visualization by optical coherence tomography.
    Bouki KP; Sakkali EK; Apostolou TS
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):625-7. PubMed ID: 21735524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography (OCT) evaluation after coronary stenting: the "black hole" and other low OCT signal-intensity areas.
    Landmesser U
    EuroIntervention; 2012 Apr; 7(12):1367-71. PubMed ID: 22522547
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.
    Costa MA; Sabate M; Angiolillo DJ; Jimenez-Quevedo P; Teirstein P; Carter A; Leon MB; Moses J; Zenni M; Yakubov S; Guzman LA; Gilmore P; Macaya C; Bass TA
    Am J Cardiol; 2006 Jan; 97(2):203-6. PubMed ID: 16442364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruptured-plaque-like appearance of restenotic tissue following sirolimus-eluting stent implantation: an optical coherence tomography case study.
    Otake H; Shite J; Shinke T
    J Invasive Cardiol; 2011 Mar; 23(3):E49-50. PubMed ID: 21364249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A; Costa JR; Feres F
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 11. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extremely Late Catch-Up Phenomenon After First-Generation Sirolimus-Eluting Stent in the Left Main Stem: Insights From Optical Coherence Tomography.
    Naganuma T; Fujino Y; Tahara S; Mitomo S; Basavarajaiah S; Nakamura S
    JACC Cardiovasc Interv; 2015 Dec; 8(14):e237-9. PubMed ID: 26718525
    [No Abstract]   [Full Text] [Related]  

  • 13. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography.
    Sawada T; Shite J; Shinke T; Tanino Y; Ogasawara D; Kawamori H; Kato H; Miyoshi N; Yoshino N; Hirata K
    J Cardiol; 2008 Dec; 52(3):290-5. PubMed ID: 19027609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
    Meredith IT; Whitbourn R; Scott D; El-Jack S; Zambahari R; Stone GW; Teirstein PS; Starzyk RM; Allocco DJ; Dawkins KD
    EuroIntervention; 2011 May; 7(1):84-90. PubMed ID: 21550907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optical coherence tomography-guided stent implantation].
    Jabłoński M; Koziński M; Rychter M; Radomski M; Białoszyński T; Sukiennik A; Kubica J
    Kardiol Pol; 2009 Oct; 67(10):1140-5. PubMed ID: 20017084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis.
    Nagai H; Ishibashi-Ueda H; Fujii K
    Catheter Cardiovasc Interv; 2010 May; 75(6):961-3. PubMed ID: 20146342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A newly formed and ruptured atheromatous plaque within neointima after drug-eluting stent implantation: 2-year follow-up intravascular ultrasound and optical coherence tomography studies.
    Oh CM; Moon J; Yu HT; Jang JY; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2011 Nov; 52(6):1028-30. PubMed ID: 22028171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Regar E; Nüesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Serruys PW
    Circulation; 2011 Aug; 124(5):612-23. PubMed ID: 21768536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings.
    Fujii K; Masutani M; Ohyanagi M
    Eur Heart J; 2008 Jun; 29(11):1385. PubMed ID: 18077442
    [No Abstract]   [Full Text] [Related]  

  • 20. Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
    Ormiston JA; Abizaid A; Spertus J; Fajadet J; Mauri L; Schofer J; Verheye S; Dens J; Thuesen L; Dubois C; Hoffmann R; Wijns W; Fitzgerald PJ; Popma JJ; Macours N; Cebrian A; Stoll HP; Rogers C; Spaulding C;
    Circ Cardiovasc Interv; 2010 Dec; 3(6):556-64. PubMed ID: 21062998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.